• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防药物相关性颌骨坏死(MRONJ):意大利专家为口腔卫生师制定的立场文件。

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists.

机构信息

Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Via L. Giuffrè 5, 90127, Palermo, PA, Italy.

Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Messina, Italy.

出版信息

Support Care Cancer. 2022 Aug;30(8):6429-6440. doi: 10.1007/s00520-022-06940-8. Epub 2022 Mar 16.

DOI:10.1007/s00520-022-06940-8
PMID:35292850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9213300/
Abstract

PURPOSE

The prevention and early diagnosis of medication-related osteonecrosis of the jaw (MRONJ) is fundamental to reducing the incidence and progression of MRONJ. Many in the field believe that dental hygienists should play an integral role in primary and secondary MRONJ prevention. However, to date, very few publications in the literature have proposed standardised MRONJ protocols, which are dedicated to dental hygienists. The aim of this study was to provide guidance to the health care providers managing MRONJ.

METHODS

The expert opinion in this study was developed by dental hygienists from the main Italian technical-scientific associations (Italian Dental Hygienists Association, AIDI and National Union of Dental Hygienists, UNID) and authors of the latest Italian recommendations regarding MRONJ from the field of dentistry and maxillofacial surgery.

RESULTS

The oral care protocol outlined in this position paper is focused on the role of dental hygienist in patients at risk or affected by MRONJ, and it regards 3 main issues: primary prevention, secondary prevention and supporting the treatment of MRONJ. Each issue contains easy-to-apply indications and procedures, as described by the authors, regarding the role of the dental hygienist.

CONCLUSION

Referring to the main issues under consideration (primary prevention, secondary prevention and the treatment of MRONJ), a clinical examination of periodontal tissue is critical in preventing MRONJ. It is the opinion of the authors of this study that the application of a periodontal screening score is fundamental in defining personalised strategies for patients at risk of MRONJ. By means of these basic procedures, a protocol for assisting the health care provider and the presentation of a practical approach for patients at risk or affected by MRONJ are described in this study.

摘要

目的

预防和早期诊断药物相关性颌骨坏死(MRONJ)对于降低 MRONJ 的发生率和进展至关重要。许多领域的专家认为,口腔卫生师应在 MRONJ 的一级和二级预防中发挥重要作用。然而,迄今为止,文献中很少有出版物提出专门针对口腔卫生师的标准化 MRONJ 方案。本研究旨在为管理 MRONJ 的医疗保健提供者提供指导。

方法

本研究中的专家意见由来自意大利主要技术科学协会(意大利口腔卫生师协会 AIDI 和全国口腔卫生师联盟 UNID)的口腔卫生师以及来自牙科和颌面外科领域的意大利最新 MRONJ 建议的作者提出。

结果

本立场文件中概述的口腔护理方案侧重于口腔卫生师在 MRONJ 高危或受影响患者中的作用,涉及 3 个主要问题:一级预防、二级预防和支持 MRONJ 的治疗。每个问题都包含作者描述的口腔卫生师角色的易于实施的适应症和程序。

结论

在考虑的主要问题(一级预防、二级预防和 MRONJ 的治疗)中,对牙周组织的临床检查对于预防 MRONJ 至关重要。本研究的作者认为,应用牙周筛查评分对于确定 MRONJ 高危患者的个性化策略至关重要。通过这些基本程序,本研究描述了一种辅助医疗保健提供者的方案和一种针对 MRONJ 高危或受影响患者的实用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/ec87ac3131e0/520_2022_6940_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/c88a9f64e494/520_2022_6940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/807f1101092b/520_2022_6940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/ec87ac3131e0/520_2022_6940_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/c88a9f64e494/520_2022_6940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/807f1101092b/520_2022_6940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9213300/ec87ac3131e0/520_2022_6940_Fig3_HTML.jpg

相似文献

1
The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists.预防药物相关性颌骨坏死(MRONJ):意大利专家为口腔卫生师制定的立场文件。
Support Care Cancer. 2022 Aug;30(8):6429-6440. doi: 10.1007/s00520-022-06940-8. Epub 2022 Mar 16.
2
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
3
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.药物相关性颌骨坏死 (MRONJ) 的预防和诊断:意大利 2020 年共识更新。
Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998.
4
[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].[关于药物性颌骨坏死(MRONJ)的立场文件]
Wien Med Wochenschr. 2016 Feb;166(1-2):68-74. doi: 10.1007/s10354-016-0437-2.
5
Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.药物相关性颌骨坏死:癌症和骨转移患者的预防、诊断和管理。
Cancer Treat Rev. 2018 Sep;69:177-187. doi: 10.1016/j.ctrv.2018.06.007. Epub 2018 Jun 18.
6
A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities.一项关于不同预防性牙科护理方式与药物相关性颌骨坏死(MRONJ)发病情况的回顾性研究。
Support Care Cancer. 2022 Feb;30(2):1723-1729. doi: 10.1007/s00520-021-06587-x. Epub 2021 Sep 27.
7
MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw.MASCC/ISOO 临床实践声明:原发性乳腺癌患者的辅助骨修饰剂 - 预防与药物相关的颌骨坏死。
Support Care Cancer. 2024 Jul 25;32(8):547. doi: 10.1007/s00520-024-08687-w.
8
Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report.骨质疏松症治疗患者的颌骨坏死:九年经验报告。
Arch Endocrinol Metab. 2023 May 12;67(4):e000612. doi: 10.20945/2359-3997000000612.
9
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
10
The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention.《药物相关性颌骨坏死风险患者的口腔管理:初级预防的新模式》。
Biomed Res Int. 2018 Sep 16;2018:2684924. doi: 10.1155/2018/2684924. eCollection 2018.

引用本文的文献

1
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
2
Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study.在有药物相关性颌骨坏死风险的患者中,以光生物调节作为辅助方式进行手术拔牙:一项回顾性研究。
BMC Oral Health. 2025 Apr 24;25(1):627. doi: 10.1186/s12903-025-05776-y.
3
Omega-3 attenuates the severity of medication-related osteonecrosis of the jaws in rats treated with zoledronate.

本文引用的文献

1
RE: MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ).关于:颌骨药物相关性骨坏死(MRONJ)。
J Oral Maxillofac Surg. 2022 Jan;80(1):2-3. doi: 10.1016/j.joms.2021.09.021. Epub 2021 Oct 16.
2
The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.药物相关性颌骨坏死 (MRONJ) 的治疗:仅手术与联合方案的系统评价和荟萃分析。
Int J Environ Res Public Health. 2021 Aug 10;18(16):8432. doi: 10.3390/ijerph18168432.
3
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
ω-3可减轻唑来膦酸治疗的大鼠颌骨药物性骨坏死的严重程度。
PLoS One. 2025 Mar 26;20(3):e0320413. doi: 10.1371/journal.pone.0320413. eCollection 2025.
4
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS.乳腺癌和前列腺癌患者CTIBL管理中的药物相关性骨坏死(MRONJ)。SIPMO和SIOMMMS联合报告
J Bone Oncol. 2024 Dec 16;50:100656. doi: 10.1016/j.jbo.2024.100656. eCollection 2025 Feb.
5
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw.《中国颌骨药物相关性骨坏死诊断与临床治疗专家共识》
J Bone Oncol. 2024 Nov 19;49:100650. doi: 10.1016/j.jbo.2024.100650. eCollection 2024 Dec.
6
Dental Hygienists' Awareness of Medication-Related Osteonecrosis of the Jaw in Private Dental Clinics in Japan.日本私人牙科诊所中牙科保健员对药物相关性颌骨坏死的认知
Gerontol Geriatr Med. 2024 Oct 31;10:23337214241292794. doi: 10.1177/23337214241292794. eCollection 2024 Jan-Dec.
7
Potential role of comprehensive dental care in preventing medication related osteonecrosis of the jaw (MRONJ): a single centre study.综合口腔护理在预防药物相关性颌骨坏死(MRONJ)中的潜在作用:单中心研究。
BMC Oral Health. 2024 Oct 26;24(1):1291. doi: 10.1186/s12903-024-05081-0.
8
Letter to editor regarding "bone modifying agents in breast cancer patients as adjuvant therapy and prevention of cancer treatment-induced bone loss (CTIBL): Evaluation of risk of medication-related osteonecrosis of the jaw (MRONJ)".致编辑的信:关于“乳腺癌患者使用骨改良药物作为辅助治疗及预防癌症治疗引起的骨丢失(CTIBL):颌骨药物相关性骨坏死(MRONJ)风险评估”
Support Care Cancer. 2024 Oct 1;32(10):698. doi: 10.1007/s00520-024-08891-8.
9
Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review.药物假定与药物不良反应认知。知情权。骨改良药物案例:一项系统综述。
Front Oral Health. 2024 Aug 1;5:1441601. doi: 10.3389/froh.2024.1441601. eCollection 2024.
10
How we manage medication-related osteonecrosis of the jaw.我们如何管理药物相关性颌骨坏死。
Eur J Med Res. 2024 Aug 2;29(1):402. doi: 10.1186/s40001-024-01912-6.
感染是导致药物相关性颌骨坏死(MRONJ)的一个重要因素。
Medicina (Kaunas). 2021 May 9;57(5):463. doi: 10.3390/medicina57050463.
4
Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association.《预防草绿色链球菌感染性心内膜炎:美国心脏协会科学声明》。
Circulation. 2021 May 18;143(20):e963-e978. doi: 10.1161/CIR.0000000000000969. Epub 2021 Apr 15.
5
The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw.免疫反应在药物相关性颌骨坏死发展中的作用。
Front Immunol. 2021 Feb 25;12:606043. doi: 10.3389/fimmu.2021.606043. eCollection 2021.
6
Efficacy of complementary treatment with autologous platelet concentrates and/or mesenchymal stem cells in chemical osteonecrosis of the jaw. Systematic review of the literature.自体血小板浓缩物和/或间充质干细胞辅助治疗颌骨化学性骨坏死的疗效。文献系统评价
J Stomatol Oral Maxillofac Surg. 2022 Feb;123(1):51-58. doi: 10.1016/j.jormas.2021.01.015. Epub 2021 Feb 17.
7
The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review.使用抗吸收药物的正畸治疗患者发生颌骨坏死及不良后果的风险:一项系统评价。
Heliyon. 2021 Jan 13;7(1):e05914. doi: 10.1016/j.heliyon.2021.e05914. eCollection 2021 Jan.
8
A 12-month randomized controlled trial evaluating erythritol air-polishing versus curette/ultrasonic debridement of mandibular furcations in supportive periodontal therapy.一项为期 12 个月的随机对照试验,评估了在下颌磨牙分叉区牙周支持治疗中,使用赤藓糖醇空气抛光与刮治/超声洁治的疗效。
BMC Oral Health. 2021 Jan 21;21(1):38. doi: 10.1186/s12903-021-01397-3.
9
Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents.评估有放疗史和骨改良药物暴露史的癌症患者颌骨坏死的诊断标准。
Radiother Oncol. 2021 Mar;156:275-280. doi: 10.1016/j.radonc.2020.12.026. Epub 2020 Dec 26.
10
Efficacy of laser monotherapy or non-surgical mechanical instrumentation in the management of untreated periodontitis patients. A systematic review and meta-analysis.激光单疗法或非手术机械器械治疗未经治疗的牙周炎患者的疗效。系统评价和荟萃分析。
Clin Oral Investig. 2021 Feb;25(2):375-391. doi: 10.1007/s00784-020-03584-y. Epub 2020 Nov 10.